Online health education by topic/speaker

(For Health Professionals)

Webinars

Craig Kessler, MD, MACP

VTECancerWRAP- A Leading Investigator, First Person Clinical Report: Focus on the Foundation Role of LMWH for VTE Management in Patients with Cancer

Webcast
Thrombosis-related complications are common in patients with malignant diseases. Estimates of the prevalence of cancer among patients with venous thrombosis vary from 3% to 18%, and up to 35% of patients with cancer eventually acquire a VTE at some point in the natural history of their disease. It is now understood that the pathogenic mechanisms of thrombosis in the cancer patient involve a complex interaction among the tumor cell, the patient, and the coagulation system. Risk factors and mechanisms for thrombosis include activation of the coagulation system, platelet activation, endothelial damage, indwelling venous access devices, direct effects of chemotherapy/hormonal therapy, and host inflammatory responses. With these issues in mind, this VTECancerWRAP: A Leading Investigator, First Person Clinical Report®is one-stop CME-accredited program that provides superior quality consultation, guidance, recommendations, and clinical directives for managing cancer patients with VTE. This multimedia program, accompanied by landmark trials, guideline statements, and PowerPoint® resources, is presented by Craig M. Kessler, MD, MACP, Professor of Medicine and Pathology, Director of Division of Coagulation in the Department of Laboratory Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.

The Science and Medicine of Thrombosis in Cancer

[NEW]
Craig M. Kessler, MD, from Georgetown University Medical Center, chairs a faculty of thrombosis experts who discuss recent advances in thrombosis and cancer, with a focus on mechanisms, mortality, therapeutics, and optimal approaches to primary and secondary thromboprophylaxis in cancer patients. The presentations examine the evolving and foundation role of low molecular weight heparins, with an emphasis on applying guidelines and recent trials to the front lines of specialty practice.



The Science and Medicine of Cancer and Thrombosis Management
Webcast


This international CME Clinical Excellence WebCAST focused on The Science and Medicine of Thrombosis Management in the Setting of Cancer includes discussions of diagnosis, risk stratification, patient assessment, and outcome-effective prophylaxis and management of patients at risk for thrombosis-related disorders in the setting of cancer and related conditions. The educational and program objectives are to provide evidence-based information, using fair balance and scientific rigor, for clinical specialists, investigators, and academicians from the fields of oncology, thrombosis medicine, hematology, coagulation, and internal medicine to optimize care of patients at risk for thrombosis-related disorders. Join Program Chairman Craig Kessler, MD, of Georgetown University Medical Center, and distinguished presenters Samuel Z. Goldhaber, MD of Harvard Medical School and Frederick Rickles, MD, of The George Washington University, as they review the latest guidelines and strategies for managing the risk of thrombosis in the cancer patient.




VTE Prophylaxis in the Setting of Cancer: A Year 2008 Best Practice Update on Cancer and Thrombosis

Webcast
Participants in this CME-certified WebCAST will: review recent trials, research, and expert analysis of issues focused on thrombosis and cancer; learn how national guidelines for thrombosis prevention should impact management of patients with cancer; learn strategies for risk-directed prophylaxis against DVT in at risk patients with cancer; be able to explain how to assess and manage special needs of cancer patients at risk for DVT, with a focus on protecting against recurrent DVT; be able to describe how to risk stratify patients undergoing cancer surgery, and implement ACCP-mandated pharmacologic and non-pharmacologic measures aimed at DVT prophylaxis; review landmark clinical trials focusing on DVT prophylaxis in patients with cancer; be able to explain how to appropriately use the range of pharmacologic options available for thrombosis management in patients with malignancy. The educational activity is designed for all physicians, academicians, researchers, investigators, and program directors from the fields of thrombosis, oncology, and haemostasis who manage patients with thrombosis-related disorders, including oncologists, hematologists, coagulation experts, internists, nurse practicioners, and related disciplines.



Cancer, Clotting, and Controversies: Critical Challenges and Landmark Advances in Thrombosis Management

Webcast
Participants in this CME-certified WebCAST will: review recent trials, research, and expert analysis of issues focused on thrombosis and cancer; specify strategies for risk-directed prophylaxis against DVT in at risk patients with cancer; explain how to assess and manage special needs of cancer patients at risk for DVT, with a focus on protecting against recurrent DVT; describe how to risk stratify patients undergoing cancer surgery, and implement ACCP-mandated pharmacologic and non-pharmacologic measures aimed at DVT prophylaxis; review landmark clinical trials focusing on DVT prophylaxis in patients with cancer; explain how to appropriately use the range of pharmacologic options available for thrombosis management in patients with malignancy. The program is intended for oncologists, hematologists, coagulation experts, internists, nurse practicioners, and related disciplines.